HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P Heeringa Selected Research
P Heeringa Research Topics
Disease
8
Glomerulonephritis
06/2012 - 03/2000
6
Vasculitis (Vasculitides)
01/2021 - 08/2003
5
Inflammation (Inflammations)
06/2012 - 02/2001
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
08/2010 - 11/2003
4
Systemic Vasculitis
05/2009 - 11/2003
3
Necrosis
08/2010 - 12/2003
3
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2009 - 02/2001
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2017 - 05/2009
2
Atherosclerosis
11/2008 - 12/2005
1
Infections
01/2021
1
Hemorrhagic Shock
06/2012
1
Rheumatoid Arthritis
05/2009
1
Atherosclerotic Plaque (Atheroma)
12/2005
1
Pleurisy (Pleuritis)
07/2004
1
Pneumonia (Pneumonitis)
07/2004
1
Microscopic Polyangiitis
11/2003
1
Churg-Strauss Syndrome (Allergic Angiitis)
11/2003
1
Ulcerative Colitis
05/2002
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2002
1
Nephritis
12/2001
1
Vascular Diseases (Vascular Disease)
02/2001
1
Thrombosis (Thrombus)
03/2000
1
Proteinuria
03/2000
Drug/Important Bio-Agent (IBA)
10
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
01/2021 - 08/2003
4
Autoantibodies
IBA
01/2017 - 05/2004
4
Proteins (Proteins, Gene)
FDA Link
06/2012 - 02/2001
4
Peroxidase (Myeloperoxidase)
IBA
10/2009 - 11/2003
3
Nitric Oxide (Nitrogen Monoxide)
FDA Link
05/2002 - 02/2001
2
antiglomerular basement membrane antibody
IBA
06/2012 - 03/2000
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
08/2010 - 02/2001
2
Myeloblastin (Proteinase 3)
IBA
05/2009 - 11/2003
2
Immunoglobulin G (IgG)
IBA
11/2008 - 04/2007
2
CD40 Ligand (CD40L)
IBA
11/2008 - 12/2005
2
Antibodies
IBA
11/2008 - 08/2003
2
Complement System Proteins (Complement)
IBA
04/2007 - 01/2007
2
Immunoglobulins (Immunoglobulin)
IBA
01/2007 - 12/2003
2
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
05/2002 - 02/2001
2
Peroxynitrous Acid (Peroxynitrite)
IBA
12/2001 - 02/2001
1
Nuclear Proteins (Protein, Nuclear)
IBA
01/2017
1
HMGB1 Protein (HMG1)
IBA
01/2017
1
E-Selectin
IBA
06/2012
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
06/2012
1
Messenger RNA (mRNA)
IBA
06/2012
1
Lipopolysaccharides
IBA
08/2010
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2010
1
Chemokines
IBA
10/2009
1
Chemokine Receptors
IBA
10/2009
1
Peptide Hydrolases (Proteases)
FDA Link
05/2009
1
Immunoglobulin M (IgM)
IBA
11/2008
1
oxidized low density lipoprotein
IBA
11/2008
1
Apolipoproteins E (ApoE)
IBA
11/2008
1
Monoclonal Antibodies
IBA
04/2007
1
Fas Ligand Protein (Fas Ligand)
IBA
07/2004
1
Antigen-Antibody Complex (Immune Complex)
IBA
12/2003
1
HLA-DR Antigens (HLA-DR)
IBA
05/2002
1
Fibrinogen (Factor I)
FDA Link
12/2001
1
anti-Thy antibody
IBA
12/2001
1
Superoxides (Superoxide)
IBA
12/2001
1
Nitric Oxide Synthase (NO Synthase)
IBA
02/2001
1
Nitrogen
IBA
03/2000
1
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
03/2000
1
Urea (Carbamide)
FDA Link
Generic
03/2000
Therapy/Procedure
1
Intravenous Injections
07/2004